ARCHIVES

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

October 24, 1997

Obey Strikes Again, Earmarks NCI Positions

July 2, 1976

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center.

December 7, 2001

ASCO Teleconference Set For Nov. 12

October 31, 1986

Regulations Threaten Clinical Trials Higgins contends

May 16, 1980